Court Denies Preemption Plea In Generic-Drug Case

Law360, New York (October 6, 2009, 5:46 PM EDT) -- In rejecting a bid by generic-drug divisions of pharmaceutical company URL Pharma Inc. to get state law tort claims over the anti-inflammatory Sulindac dismissed by arguing that the claims are preempted by federal law, a New Hampshire federal judge has joined the ranks of courts that have rejected the preemption argument in a generic-drug liability case.

Judge Joseph N. Laplante on Sept. 30 denied the defendant's motion to dismiss the case based on the federal preemption argument.

Pointing to the U.S. Supreme Court's March ruling in...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Bartlett et al v. Mutual Pharmaceutical Company, Inc. et al


Case Number

1:08-cv-00358

Court

New Hampshire

Nature of Suit

Personal Inj. Prod. Liability

Judge

Joseph N. Laplante

Date Filed

August 28, 2008

Law Firms

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.